ARCHIVES

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Data Falsification Charge To Be Aired

June 27, 1980

NCI Program Announcements

May 5, 2000

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986

NCI: The Times Have Been “Confusing,” Acting NCI Director Niederhuber Admits in Memo.

June 9, 2006

NCI AIDS Malignancy Bank Accepts Requests; RFA Available

December 1, 1995